Clinical trial
The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene
NCT01786980 is registered in ClinicalTrials.gov with Eastern Hepatobiliary Surgery Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene
- Lead sponsor
- Eastern Hepatobiliary Surgery Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- December 31, 2015
- Enrollment
- 300 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma;, radical hepatic resection;